Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta

Citation
A. Galicka et al., Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta, EUR J BIOCH, 268(7), 2001, pp. 2172-2178
Citations number
43
Categorie Soggetti
Biochemistry & Biophysics
Journal title
EUROPEAN JOURNAL OF BIOCHEMISTRY
ISSN journal
00142956 → ACNP
Volume
268
Issue
7
Year of publication
2001
Pages
2172 - 2178
Database
ISI
SICI code
0014-2956(200104)268:7<2172:DOTIPM>2.0.ZU;2-J
Abstract
We have studied the structure and metabolism of type I procollagen in a cas e of perinatal lethal osteogenesis imperfecta (OI) type II. Cultured skin f ibroblasts from the proband synthesized both normal and abnormal forms of t ype I procollagen. Some abnormal, overmodified molecules were secreted by O I cells, although less efficiently than normal molecules from control cells . The OI fibroblasts accumulated large amounts of abnormal pro alpha1(I) an d pro alpha2(I) chains intracellularly. The extracellular collagenolytic ac tivity was decreased compared to control cells. Furthermore, OI cells produ ced less type I procollagen and demonstrated lower capacity to synthesize D NA than control cells. We have found that in contrast to prolinase activity , the activity of prolidase tan enzyme essential for collagen synthesis and cell growth) is also significantly reduced in OI cells. No differences wer e found in the amount of the enzyme protein recovered from both the OI and control cells. However, we found that expressions of beta1 integrin and ins ulin-like growth factor-I receptor (receptors known to play an important ro le in up regulation of prolidase activity) were decreased in OI cells compa red to control cells. The decrease in prolidase activity may provide an imp ortant mechanism of altered cell growth and collagen metabolism involved in producing the perinatal lethal form of the OI phenotype.